Home › Markets › Health Care › ARTL

Artelo Biosciences Inc. (ARTL)

ARTL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$2.98
-4.18% on the day
Market cap
$1.6M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerARTL on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001621221
SEC industry codePharmaceutical Preparations
Incorporated inNV

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-05-26
Latest annual report
FORM 10-K
10-K2026-02-24
Latest quarterly / interim
FORM 10-Q/A
10-Q/A2026-08-20
Latest current report
FORM 8-K
8-K2026-10-09
Latest proxyDEFA14A2026-07-16

Source: SEC EDGAR submissions feed, 465 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
LABTLakewood-Amedex Biotherapeutics Inc.$0.6939-5.08%$1.6M
BDRXBiodexa Pharmaceuticals plc American Depositary Shs$0.3502-8.61%$1.5M
OGENOragenics Inc.$0.4469-0.16%$2.0M
GNPXGenprex Inc.$2.51-6.69%$2.1M
SILOSilo Pharma Inc.$1.22-18.12%$2.1M
PPBTPurple Biotech Ltd.$1.36-1.45%$2.2M
SPRCSciSparc Ltd.$3.94-3.43%$2.3M
ELABPMGC Holdings Inc.$2.96-2.95%$2.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier